Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Weighted Average and Diluted): 2020-2025

Historic EPS (Weighted Average and Diluted) for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to -$0.48.

  • iSpecimen's EPS (Weighted Average and Diluted) rose 77.14% to -$0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.89, marking a year-over-year increase of 58.36%. This contributed to the annual value of -$17.58 for FY2024, which is 28.39% up from last year.
  • Per iSpecimen's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.48 for Q3 2025, which was down 14.29% from -$0.42 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's EPS (Weighted Average and Diluted) peaked at $0.08 during Q4 2021, and registered a low of -$6.77 during Q4 2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$2.10 (2024), whereas its average is -$2.92.
  • As far as peak fluctuations go, iSpecimen's EPS (Weighted Average and Diluted) skyrocketed by 104.95% in 2021, and later crashed by 2,720.83% in 2023.
  • iSpecimen's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.08 in 2021, then crashed by 400.00% to -$0.24 in 2022, then tumbled by 2,720.83% to -$6.77 in 2023, then increased by 7.24% to -$6.28 in 2024, then surged by 77.14% to -$0.48 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.48 in Q3 2025, compared to -$0.42 in Q2 2025 and -$0.71 in Q1 2025.